Catalog Home Page

Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat

Skelly, B.J., Petrus, D.J. and Nicholls, P.K. (2003) Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat. Journal of Small Animal Practice, 44 (6). pp. 269-272.

[img] PDF - Authors' Version
Download (79kB)
    Link to Published Version: http://dx.doi.org/10.1111/j.1748-5827.2003.tb00154...
    *Subscription may be required

    Abstract

    Hyperadrenocorticism occurs much less frequently in cats than in dogs and, at present, is more difficult to manage successfully. This report documents the use of the steroid synthesis inhibitor trilostane for the treatment of hyperadrenocorticism in a domestic shorthaired cat with pituitary-dependent disease. Although trilostane was able to alleviate the severity of the clinical signs and was well tolerated, the cat subsequently died of renal failure secondary to a fungal infection of the urinary tract.

    Publication Type: Journal Article
    Murdoch Affiliation: School of Veterinary and Biomedical Sciences
    Publisher: Blackwell Publishing
    Copyright: British Small Animal Veterinary Association
    URI: http://researchrepository.murdoch.edu.au/id/eprint/554
    Item Control Page

    Downloads

    Downloads per month over past year